G. Holmgren, A. Bjö-rkman, and J. Gil, Amodiaquine resistance is not related to rare findings of pfmdr1 gene amplifications in Kenya, Tropical Medicine and International Health, vol.43, issue.12, pp.1808-1812, 2006.
DOI : 10.1186/1475-2875-2-31

G. Holmgren, J. Hamrin, J. Svard, A. Martensson, J. Gil et al., Selection of pfmdr1 mutations after amodiaquine monotherapy and amodiaquine plus artemisinin combination therapy in East Africa, Infection, Genetics and Evolution, vol.7, issue.5, pp.562-569, 2007.
DOI : 10.1016/j.meegid.2007.03.005

C. Sisowath, J. Stromberg, A. Martensson, M. Msellem, C. Obondo et al., 86N Coding Alleles by Artemether???Lumefantrine (Coartem), The Journal of Infectious Diseases, vol.191, issue.6, pp.1014-1017, 2005.
DOI : 10.1086/427997

C. Sisowath, P. Ferreira, L. Bustamante, S. Dahlstrom, A. Martensson et al., The role of pfmdr1 in Plasmodium falciparum tolerance to artemether-lumefantrine in Africa, Tropical Medicine & International Health, vol.15, issue.6, pp.736-742, 2007.
DOI : 10.1111/j.1365-3156.2007.01843.x

A. Djimdé, B. Fofana, I. Sagara, B. Sidibe, S. Toure et al., Efficacy , safety, and selection of molecular markers of drug resistance by two ACTs in Mali, Am J Trop Med Hyg, vol.78, pp.455-461, 2008.

A. Tshefu, O. Gaye, K. Kayentao, R. Thompson, K. Bhatt et al., Efficacy and safety of a fixed-dose oral combination of pyronaridine-artesunate compared with artemether-lumefantrine in children and adults with uncomplicated Plasmodium falciparum malaria: a randomised non-inferiority trial, The Lancet, vol.375, issue.9724, pp.1457-1467
DOI : 10.1016/S0140-6736(10)60322-4

N. Valecha, A. Phyo, M. Mayxay, P. Newton, S. Krudsood et al., An Open-Label, Randomised Study of Dihydroartemisinin-Piperaquine Versus Artesunate-Mefloquine for Falciparum Malaria in Asia, PLoS ONE, vol.7, issue.7, p.11880, 2010.
DOI : 10.1371/journal.pone.0011880.s009

S. Abdulla, I. Sagara, S. Borrmann, D. 'alessandro, U. Gonzalez et al., Efficacy and safety of artemether-lumefantrine dispersible tablets compared with crushed commercial tablets in African infants and children with uncomplicated malaria: a randomised, single-blind, multicentre trial, The Lancet, vol.372, issue.9652, pp.1819-1827, 2008.
DOI : 10.1016/S0140-6736(08)61492-0

I. Sagara, S. Rulisa, W. Mbacham, I. Adam, K. Sissoko et al., Efficacy and safety of a fixed dose artesunate-sulphamethoxypyrazine-pyrimethamine compared to artemether-lumefantrine for the treatment of uncomplicated falciparum malaria across Africa: a randomized multi-centre trial, Malaria Journal, vol.8, issue.1, p.63, 2009.
DOI : 10.1186/1475-2875-8-63

B. Ngasala, M. Malmberg, A. Carlsson, P. Ferreira, M. Petzold et al., Efficacy and Effectiveness of Artemether-Lumefantrine after Initial and Repeated Treatment in Children < 5 Years of Age with Acute Uncomplicated Plasmodium falciparum Malaria in Rural Tanzania: A Randomized Trial, Clinical Infectious Diseases, vol.52, issue.7, pp.873-882, 2011.
DOI : 10.1093/cid/cir066

W. Verret, E. Arinaitwe, H. Wanzira, V. Bigira, A. Kakuru et al., Effect of Nutritional Status on Response to Treatment with Artemisinin-Based Combination Therapy in Young Ugandan Children with Malaria, Antimicrobial Agents and Chemotherapy, vol.55, issue.6, pp.2629-2635, 2011.
DOI : 10.1128/AAC.01727-10

G. Adjei, J. Kurtzhals, O. Rodrigues, M. Alifrangis, L. Hoegberg et al., Amodiaquine-artesunate vs artemether-lumefantrine for uncomplicated malaria in Ghanaian children: a randomized efficacy and safety trial with one year follow-up, Malaria Journal, vol.7, issue.1, p.127, 2008.
DOI : 10.1186/1475-2875-7-127

M. Ramharter, F. Kurth, A. Schreier, J. Nemeth, I. Glasenapp et al., Fixed???Dose Pyronaridine???Artesunate Combination for Treatment of Uncomplicated Falciparum Malaria in Pediatric Patients in Gabon, The Journal of Infectious Diseases, vol.198, issue.6, pp.911-919, 2008.
DOI : 10.1086/591096

J. Ndiaye, F. B. Gueye, A. Tine, R. Ndiaye, D. Tchania et al., Repeated treatment of recurrent uncomplicated Plasmodium falciparum malaria in Senegal with fixed-dose artesunate plus amodiaquine versus fixed-dose artemether plus lumefantrine: a randomized, open-label trial, Malaria Journal, vol.10, issue.1, p.237, 2011.
DOI : 10.1111/j.1365-3156.2008.02119.x

C. Plowe, O. Doumbo, A. Djimde, K. Kayentao, Y. Diourte et al., Chloroquine treatment of uncomplicated Plasmodium falciparum malaria in Mali: parasitological resistance vs. therapeutic efficacy, Am J Trop Med Hyg, vol.64, pp.242-246, 2001.

D. Diallo, O. Doumbo, C. Plowe, T. Wellems, E. Emanuel et al., Community Permission for Medical Research in Developing Countries, Clinical Infectious Diseases, vol.41, issue.2, pp.255-259, 2005.
DOI : 10.1086/430707

H. Kaddouri, A. Djimdé, S. Dama, A. Kodio, M. Tekete et al., Baseline in vitro efficacy of ACT component drugs on Plasmodium falciparum clinical isolates from Mali, International Journal for Parasitology, vol.38, issue.7, pp.791-798, 2008.
DOI : 10.1016/j.ijpara.2007.12.002

E. Tjitra, S. Suprianto, B. Currie, P. Morris, J. Saunders et al., Therapy of uncomplicated falciparum malaria: a randomized trial comparing artesunate plus sulfadoxinepyrimethamine versus sulfadoxine-pyrimethamine alone in Irian Jaya, Indonesia, Am J Trop Med Hyg, vol.65, pp.309-317, 2001.

J. Ndiaye, M. Randrianarivelojosia, I. Sagara, P. Brasseur, I. Ndiaye et al., Randomized, multicentre assessment of the efficacy and safety of ASAQ ??? a fixed-dose artesunate-amodiaquine combination therapy in the treatment of uncomplicated Plasmodium falciparum malaria, Malaria Journal, vol.8, issue.1, p.125, 2009.
DOI : 10.1186/1475-2875-8-125

H. Bukirwa, A. Yeka, M. Kamya, A. Talisuna, K. Banek et al., Artemisinin Combination Therapies for Treatment of Uncomplicated Malaria in Uganda, PLoS Clinical Trials, vol.2, issue.1, pp.7-56, 2006.
DOI : 10.1371/journal.pctr.0010007.sd002